Xvivo Perfusion AB (XVIPF)
OTHER OTC:XVIPF
Holding XVIPF?
Track your performance easily

Xvivo Perfusion AB (XVIPF) Financial Statements

5 Followers

Xvivo Perfusion AB Financial Overview

Xvivo Perfusion AB's market cap is currently ―. The company's EPS TTM is $0.361; its P/E ratio is 132.51; Xvivo Perfusion AB is scheduled to report earnings on October 24, 2024, and the estimated EPS forecast is $0.07. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenuekr 140.62Mkr 131.51Mkr 96.83Mkr 94.29Mkr 92.65M
Gross Profitkr 104.82Mkr 94.86Mkr 69.37Mkr 67.51Mkr 65.22M
EBITkr 11.21Mkr 18.81Mkr -4.66Mkr 4.14Mkr 4.62M
EBITDAkr 11.21Mkr 18.81Mkr -4.66Mkr 4.14Mkr 4.62M
Net Income Common Stockholderskr 14.18Mkr 734.00Kkr 5.40Mkr 7.53Mkr 4.76M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investmentskr 197.95Mkr 246.54Mkr 314.56Mkr 317.88Mkr 339.78M
Total Assetskr 1.74Bkr 1.73Bkr 1.64Bkr 1.58Bkr 1.52B
Total Debtkr 292.99Mkr 10.01Mkr 5.54Mkr 6.42Mkr 5.14M
Net Debtkr 95.03Mkr -236.54Mkr -309.02Mkr -311.46Mkr -334.64M
Total Liabilitieskr 292.99Mkr 302.95Mkr 259.87Mkr 239.00Mkr 224.98M
Stockholders Equitykr 1.45Bkr 1.43Bkr 1.38Bkr 1.35Bkr 1.30B
Cash Flow-
Free Cash Flowkr -12.43Mkr -109.16Mkr 16.97Mkr -1.56Mkr -9.35M
Operating Cash Flowkr -12.43Mkr 21.79Mkr 16.97Mkr -1.56Mkr -9.35M
Investing Cash Flowkr -33.53Mkr -77.05Mkr -33.72Mkr -34.48Mkr -52.37M
Financing Cash Flowkr -2.49Mkr -2.80Mkr -1.62Mkr -556.00Kkr -1.86M
Currency in SEK

Xvivo Perfusion AB Earnings and Revenue History

Xvivo Perfusion AB Debt to Assets

Xvivo Perfusion AB Cash Flow

Xvivo Perfusion AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis